PET imaging of sodium-glucose cotransporters (SGLTs): unveiling metabolic dynamics in diabetes and oncology
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Molecular Metabolism, 90, S. 102055-
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2024
- Event
-
Veröffentlichung
- (where)
-
Amsterdam
- (who)
-
Elsevier BV
- (when)
-
2024
- Creator
-
Klimek, Konrad
Chen, Xinyu
Sasaki, Takanori
Groener, Daniel
Werner, Rudolf A.
Higuchi, Takahiro
- DOI
-
10.1016/j.molmet.2024.102055
- URN
-
urn:nbn:de:bvb:384-opus4-1162755
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Klimek, Konrad
- Chen, Xinyu
- Sasaki, Takanori
- Groener, Daniel
- Werner, Rudolf A.
- Higuchi, Takahiro
- Universität Augsburg
- Elsevier BV
Time of origin
- 2024
Other Objects (12)
Navigating new horizons: prospects of NET-targeted radiopharmaceuticals in precision medicine
Design, synthesis and pharmacological studies of novel multivalent and -funtional anti-Alzheimer's disease agents
Novel 18F-labeled PET Imaging Agent FV45 targeting the Renin-Angiotensin System
Moving into the Next Era of PET Myocardial Perfusion Imaging - Introduction of Novel 18F-labeled Tracers
Recent advances in radiotracers targeting norepinephrine transporter: structural development and radiolabeling improvements
Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers
Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer
Norepinephrine transporter–targeted cancer theranostics — new horizons
In vivo functional assessment of Sodium-Glucose Cotransporters (SGLTs) using [18F]Me4FDG PET in rats
New horizons in cardiac innervation imaging: introduction of novel 18F-labeled PET tracers
SPECT vs. PET in Cardiac Innervation Imaging: Clash of the Titans
SPECT vs. PET in cardiac innervation imaging: clash of the titans
Navigating new horizons: prospects of NET-targeted radiopharmaceuticals in precision medicine
Design, synthesis and pharmacological studies of novel multivalent and -funtional anti-Alzheimer's disease agents
Novel 18F-labeled PET Imaging Agent FV45 targeting the Renin-Angiotensin System
Moving into the Next Era of PET Myocardial Perfusion Imaging - Introduction of Novel 18F-labeled Tracers
Recent advances in radiotracers targeting norepinephrine transporter: structural development and radiolabeling improvements
Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers
Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer
Norepinephrine transporter–targeted cancer theranostics — new horizons
In vivo functional assessment of Sodium-Glucose Cotransporters (SGLTs) using [18F]Me4FDG PET in rats
New horizons in cardiac innervation imaging: introduction of novel 18F-labeled PET tracers
SPECT vs. PET in Cardiac Innervation Imaging: Clash of the Titans
SPECT vs. PET in cardiac innervation imaging: clash of the titans
Navigating new horizons: prospects of NET-targeted radiopharmaceuticals in precision medicine
Design, synthesis and pharmacological studies of novel multivalent and -funtional anti-Alzheimer's disease agents
Novel 18F-labeled PET Imaging Agent FV45 targeting the Renin-Angiotensin System
Moving into the Next Era of PET Myocardial Perfusion Imaging - Introduction of Novel 18F-labeled Tracers
Recent advances in radiotracers targeting norepinephrine transporter: structural development and radiolabeling improvements
Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers
Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer
Norepinephrine transporter–targeted cancer theranostics — new horizons
In vivo functional assessment of Sodium-Glucose Cotransporters (SGLTs) using [18F]Me4FDG PET in rats
New horizons in cardiac innervation imaging: introduction of novel 18F-labeled PET tracers
SPECT vs. PET in Cardiac Innervation Imaging: Clash of the Titans